F

Forte Biosciences
D

FBRX

11.760
USD
0.65
(5.85%)
مغلق
حجم التداول
1,306
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
146,210,363
أصول ذات صلة
AZN
AZN
0.510
(0.63%)
80.970 USD
BMY
BMY
-0.520
(-1.07%)
47.890 USD
GSK
GSK
0.100
(0.25%)
40.190 USD
LLY
LLY
1.29
(0.18%)
711.47 USD
MRK
MRK
1.235
(1.43%)
87.370 USD
NVO
NVO
1.540
(2.78%)
56.990 USD
NVS
NVS
0.070
(0.06%)
126.940 USD
PFE
PFE
0.155
(0.60%)
25.870 USD
SNY
SNY
0.750
(1.48%)
51.350 USD
VTRS
VTRS
-0.055
(-0.51%)
10.645 USD
المزيد
الأخبار المقالات

العنوان: Forte Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).